View Post

Novian Health Gains FDA Breakthrough Designation for Novilase Breast Therapy

In Clinical Studies News by Barbara Jacoby

Groundbreaking laser therapy offers alternative to surgery for breast cancer Novian Health Inc. has been granted Breakthrough Device designation from the U.S. Food and Drug Administration for its Novilase®Interstitial Laser System and its proposed indication for use: the focal destruction of malignant breast tumors in adult women who seek a breast conserving procedure. The FDA’s Breakthrough Device program supports the …

View Post

Breast Cancer Clinical Trial of Laser Ablation Treatment Shows Promising Results for Patients

In In The News by Barbara Jacoby

Groundbreaking Novilase Research Led by Rose Medical Center’s Dr. Barbara Schwartzberg Is Presented at San Antonio Breast Cancer Symposium A laser treatment called Novilase® Breast Therapy shows promise as a way to successfully treat small breast cancers, according to research that was led by principal investigator Barbara Schwartzberg, M.D. of Rose Medical Center. Results of the multi-center international BR-002 Novilase …